← Back to All Filings

CME Group Chief Commercial Officer Sells $3.08M in Class A Shares

Medium SignificanceNovember 2, 2026 at 8:06:57 PM EST

CME GROUP INC.

$CME4CIK: 0001156375

Subscribe to track CME

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

{"title": "CME Group Inc. Insider Transaction Update", "color": 15158332, "fields": [{"name": "Insider", "value": "Julie Winkler (Sr MD Chief Commercial Officer)", "inline": false}, {"name": "Transaction Type", "value": "Sale (Open Market)", "inline": true}, {"name": "Shares Sold", "value": "10,079", "inline": true}, {"name": "Avg Price", "value": "$305.15", "inline": true}, {"name": "Total Transaction Value", "value": "$3,075,606.85", "inline": true}, {"name": "Remaining Direct Holdings", "value": "21,482 shares", "inline": true}], "footer": {"text": "Form 4 Filing Date: 2026-11-03"}}

Comprehensive Analysis

Executive Summary

On November 2, 2026, Julie Winkler, Senior Managing Director and Chief Commercial Officer of CME Group Inc. (NASDAQ: CME), executed an open-market sale of 10,079 shares of Class A Common Stock. The shares were sold at a weighted average price of $305.15, resulting in gross proceeds of approximately $3.08 million.

Transaction Breakdown

  • Insider: Julie Winkler
  • Title: Senior Managing Director & Chief Commercial Officer
  • Security: Common Stock Class A
  • Transaction Code: S (Open market or private sale)
  • Shares Sold: 10,079 shares
  • Execution Price: $305.15 (Sold within a range of $305.11 to $305.34)
  • Gross Consideration: $3,075,606.85
  • Post-Transaction Holdings: 21,482 shares directly owned
  • Holding Reduction: Represents a ~31.9% reduction in directly held equity

Strategic Context & Analysis

The sale was executed without the indication of an active Rule 10b5-1 trading plan checkmark (<aff10b5One>0</aff10b5One>). While a disposition of roughly one-third of the officer's direct holdings represents a noteworthy liquidity event, the executive retains a substantial position of 21,482 shares valued at approximately $6.56 million at the transaction price.

Topics:#CME#CMEGroup#InsiderSelling#StockMarket#ExecutiveTrading

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.